M
Martin Pichler
H-index:69
Citation Count:1.6万
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
Clinical Significance and Therapeutic Potential of Long Non-Coding RNA H19 in Soft Tissue Sarcoma
长链非编码RNA H19在软组织肉瘤中的临床意义和治疗潜力
Cancer Medicine
IF3.1
Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis
恩福妥单抗 vedotin 联合帕博利珠单抗治疗初治转移性尿路上皮癌患者:一项奥地利真实世界分析
FGFR1/3 Signaling as an Achilles’ Heel of Phenotypic Diversity in Urothelial Carcinoma
FGFR1/3信号作为尿路上皮癌表型多样性的阿喀琉斯之踵
Characteristics and palliative management of patients with cisplatin-refractory germ cell tumours: A Global Germ Cell Cancer Collaborative Group (G3) retrospective registry study
顺铂耐药性生殖细胞肿瘤患者的特点与姑息管理:全球生殖细胞癌协作组(G3)回顾性登记研究
ANNALS OF ONCOLOGY
IF65.4
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework
癌症治疗的ERK通路激动: 证据、见解和目标发现框架
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
免疫肿瘤学联合治疗的晚期肾细胞癌和中度或低风险国际转移性肾细胞癌数据库联盟标准患者的真实世界结果: 风险组的差异有效性?
MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport Protein GRAMD1B
MiR-4646-5p在三阴性乳腺癌中作为肿瘤抑制因子并靶向胆固醇转运蛋白GRAMD1B

